logo-loader
RNS
NMC Health PLC

Wellington Mngmnt Gp - Form 8.3 - NMC Health plc

RNS Number : 9339D
Wellington Management Group LLP
24 February 2020
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

 


 

(a)

Full name of discloser:

Wellington Management Group LLP

 

(b)

Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.


 

(c)

Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

NMC Health plc

 

(d)

If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:


 

(e)

Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

21 February 2020

 

(f)

In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 


 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 


 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 


 

Class of relevant security:

Ordinary Shares (GB00B7FC0762)

 


Interests

Short Positions

 


Number

%

Number

%

 

(1)

Relevant securities owned and/or controlled:

10,068,009

4.82 %

593,792

0.28 %

 

(2)

Cash-settled derivatives:



209,508

0.10 %

 

(3)

Stock-settled derivatives (including options) and agreements to purchase/sell:

4,317

0.00 %

5,129

0.00 %

 


Total

10,072,326 *

4.83 %

808,429

0.39 %

 

* Wellington Management Group LLP does not have discretion regarding voting decisions in respect of 1,354,592 shares that are included in the total above.

 


 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 


 


 

(b)

Rights to subscribe for new securities (including directors' and other employee options)

 


 

Class of relevant security in relation to which subscription right exists:


 

Details, including nature of the rights concerned and relevant percentages:


 


 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 


 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a)

Purchases and sales

 


 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

 

Ordinary Shares (GB00B7FC0762)

Sale

13,586

8.5520 GBP

 


 

(b)

Cash-settled derivative transactions

 


 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

Ordinary Shares (GB00B7FC0762)

Equity Swap

Purchase

2

43.2660 USD

 

Ordinary Shares (GB00B7FC0762)

Equity Swap

Purchase

3

43.2660 USD

 

Ordinary Shares (GB00B7FC0762)

Equity Swap

Purchase

2

43.2660 USD

 

Ordinary Shares (GB00B7FC0762)

Equity Swap

Purchase

4

43.2660 USD

 

Ordinary Shares (GB00B7FC0762)

Equity Swap

Purchase

2

43.2660 USD

 


 

(c)

Stock-settled derivative transactions (including options)


(i)

Writing, selling, purchasing or varying


Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type e.g. American, European etc.

Expiry date

Option money paid/ received per unit










 

(ii)

Exercise

 


 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 






 


 

(d)

Other dealings (including subscribing for new securities)

 


 

Class of relevant security

Nature of dealing e.g. subscription, conversion

Details

Price per unit (if applicable)

 





 


 

4.

OTHER INFORMATION

 


 

(a)

Indemnity and other dealing arrangements

 


 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 


 

(b)

Agreements, arrangements or understandings relating to options or derivatives

 


 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 


 

(c)

Attachments

 


 

Is a Supplemental Form 8 (Open Positions) attached?

YES

 


 

Date of disclosure

24 February 2020

 

Contact name

Shaheen Hussain

 

Telephone number

44-20-7126-6099

 


 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.


SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS,

AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

1.

KEY INFORMATION


Full name of person making disclosure:

Wellington Management Group LLP

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

NMC Health plc


2.

STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)


 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type e.g. American, European etc.

Expiry date

Ordinary Shares (GB00B7FC0762)

Equity Call Option

Purchased

578

71.0000USD

American

23 Feb 20

Ordinary Shares (GB00B7FC0762)

Equity Call Option

Written

513

69.0000USD

American

23 Feb 20

Ordinary Shares (GB00B7FC0762)

Equity Put Option

Purchased

3,411

60.0000USD

American

23 Feb 20

Ordinary Shares (GB00B7FC0762)

Equity Put Option

Purchased

328

61.0000USD

American

23 Feb 20

Ordinary Shares (GB00B7FC0762)

Equity Put Option

Written

14

59.0000USD

American

23 Feb 20

Ordinary Shares (GB00B7FC0762)

Equity Put Option

Written

14

59.0000USD

American

23 Feb 20

Ordinary Shares (GB00B7FC0762)

Equity Put Option

Written

14

62.0000USD

American

23 Feb 20

Ordinary Shares (GB00B7FC0762)

Equity Put Option

Written

65

63.0000USD

American

23 Feb 20

Ordinary Shares (GB00B7FC0762)

Equity Put Option

Written

257

65.0000USD

American

23 Feb 20

Ordinary Shares (GB00B7FC0762)

Equity Put Option

Written

328

65.0000USD

American

23 Feb 20

Ordinary Shares (GB00B7FC0762)

Equity Put Option

Written

513

66.0000USD

American

23 Feb 20

Ordinary Shares (GB00B7FC0762)

Equity Put Option

Written

3,411

66.0000USD

American

23 Feb 20


3.

AGREEMENTS TO PURCHASE OR SELL ETC.


Full details should be given so that the nature of the interest or position can be fully understood:

None


It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives

The currency of all prices and other monetary amounts should be stated.

monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETXZLFLBLLXBBB
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

6 min read